During the past decade, Instituto Materno Infantil Prof. Fernando Figueira conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 1 clinical trials were completed, i.e. on average, 4.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Materno Infantil Prof. Fernando Figueira" #1 sponsor was "Instituto Materno Infantil Prof. Fernando Figueira" with 20 trials, followed by "Professor Fernando Figueira Integral Medicine Institute" with 6 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Latin American Cooperative Oncology Group" with 2 trials sponsored and "Actelion" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto Materno Infantil Prof. Fernando Figueira" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Bellisa Caldas Lopes" with 1 trials as a collaborator, "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 1 trials as a collaborator, "EVA - Grupo Brasileiro de Tumores Ginecológicos" with 1 trials as a collaborator and "Federal University of São Paulo" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Instituto Materno Infantil Prof. Fernando Figueira" are "Preeclampsia" (6 trials), "Advanced Cancer" (1 trials), "Advanced Solid Tumor" (1 trials), "Amnestic" (1 trials) and "COVID19" (1 trials). Many other conditions were trialed in "Instituto Materno Infantil Prof. Fernando Figueira" in a lesser frequency.

Most popular intervention types in "Instituto Materno Infantil Prof. Fernando Figueira" are "Drug" (23 trials), "Other" (8 trials), "Behavioral" (2 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Erdafitinib" (2 trials), "AGEN2034" (1 trials), "Acapella" (1 trials) and "Aquatic exercise" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Materno Infantil Prof. Fernando Figueira" are 23 trials for "Female" genders and 14 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Materno Infantil Prof. Fernando Figueira". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Instituto Materno Infantil Prof. Fernando Figueira, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Materno Infantil Prof. Fernando Figueira, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 10 trials that are defined as “Not Applicable".